Stock Updates

How has Thermo Fisher Scientific, Inc.:(NYSE:TMO) performed recently?

Thermo Fisher Scientific, Inc. (NYSE: TMO) is a large market cap stock with a market cap of 62072.44. It is in the Medical Laboratories & Research industry and sector Healthcare, with a current P/E of 31.56, a forward P/E of 17.5 and EPS of 4.98. At a stock price of 155.59 (-0.93%) it has a dividend yield of 0.38%.

EPS growth for the last five years have been 15.00%, more recently this last year it has grown by 4.60%. The next year growth is going to be about 10.35% and more long-term 10.50% after five years. EPS growth quarter over quarter is 5.20%. Sales growth for the past five years have been 10.30% and sales growth quarter over quarter is 9.60%.

For performance, Thermo Fisher Scientific, Inc. the past week has seen a gain of 3.09%. For the last month performance for Thermo Fisher Scientific, Inc. is 6.67%. While the last quarter is 7.33% and half year, 18.54%. Finally for the year, performance is 16.20%.

The 52-week high for Thermo Fisher Scientific, Inc., is at -1.76%, and for the 52-week low it comes to a value of 33.29%. The 20-day simple moving average is 3.68% and 11.97% for the 200-day simple moving average.

Volatility for the week is at 1.12%, and for the month it is 1.52%. Thermo Fisher Scientific, Inc., has a target price of 164.53.

In terms of debt, long term debt/equity is 0.56, and for total debt/equity Thermo Fisher Scientific, Inc. has 0.72. The gross margin is 45.50%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1 and the quick ratio is 0.7.

Insider ownership is at 0.20%, with instituitional ownership at 89.60%. Thermo Fisher Scientific, Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 395.24. The shares float is 392.91, with the float short at 1.30%, with short ratio coming to 3.5.

In terms of returns, the return on assets see Thermo Fisher Scientific, Inc., get *TBA, with its returns on investment at 7.00%. Return on equity is *TBA. So will the investors see the target price of 164.53, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment